Kathleen Haskell - Concepedia

Concepedia

Author

Kathleen Haskell

United States Military Academy

Also Known As

K M Haskell, K. Haskell, K. M. Haskell, Kathleen Haskell, Kathleen M. Haskell, Kathleen M. HASKELL, Keith Haskell

19

Publications

1.8K

Citations

13

H-Index

46

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)

KH

About

Kathleen Haskell is an author at United States Military Academy specializing in medicine, cell biology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	944
2	Cell Biology	7	7	664
3	Natural Sciences	2	2	342
4	Cellular Physiology	2	2	64
5	Endocrinology	1	1	54

Kathleen Haskell

×

15

Publications

1.8K

Citations

13

H-Index

	Year	Citations
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors Stanley F. Barnett, Deborah Defeo-Jones, Sheng Fu, Biochemical Journal	2005	394
Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product Deborah Defeo-Jones, Pearl S. Huang, Raymond E. Jones, Nature Cell RegulationNatural SciencesMolecular BiologyCell ProliferationRetinoblastoma Gene Product	1991	332
RETRACTED: Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling Qing‐Bai She, Sarat Chandarlapaty, Qing Ye, PLoS ONE	2008	315
Tumor cell sensitization to apoptotic stimuli by selective inhibition of specific Akt/PKB family members Deborah Defeo-Jones, Stanley F. Barnett, Sheng Fu, Molecular Cancer Therapeutics Chemoprevention StrategyFamily MembersApoptosisImmunologyCell Death	2005	174
A peptide–doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo Deborah Defeo-Jones, Victor M. Garsky, Bradley K. Wong, Nature Medicine UrologyProstate Tumor CellsMedicinePeptide EngineeringPeptide Therapeutic	2000	156
Allosteric inhibitors of Akt1 and Akt2: A naphthyridinone with efficacy in an A2780 tumor xenograft model Mark T. Bilodeau, Adrienne E. Balitza, J. M. HOFFMAN, Bioorganic & Medicinal Chemistry Letters Tumor BiologyMedicinePharmacotherapyAllosteric InhibitorsAnti-cancer Agent	2008	81
Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts Deborah Defeo-Jones, Gerald A. Vuocolo, Kathleen Haskell, Journal of Virology ImmunologyRetinoblastoma ProteinPathologyHpv InfectionTumor Biology	1993	61
An allosteric Akt inhibitor effectively blocks Akt signaling and tumor growth with only transient effects on glucose and insulin levels in vivo Craig Cherrin, Kathleen Haskell, Bonnie J. Howell, Cancer Biology & Therapy	2010	59
Genetic regulation of <i>β</i>2-adrenergic receptors in 3T3-L1 fibroblasts M T Nakada, Kathleen Haskell, David J. Ecker, Biochemical Journal Beta 2-Adrenergic ReceptorGeneticsGenetic RegulationGlucocorticoidCellular Physiology	1989	54
Centyrin ligands for extrahepatic delivery of siRNA Donna Klein, Shalom D. Goldberg, Christopher S. Theile, Molecular Therapy	2021	45

Page 1